Does renin‐angiotensin system blockade protect lupus nephritis patients from atherosclerotic cardiovascular events? A case‐control study
Conclusions: Our data do not support the hypothesis that ACEIs/ARBs may be protective against atherosclerotic CVEs in LN patients. This article is protected by copyright. All rights reserved.
Source: Arthritis Care and Research - Category: Rheumatology Authors: Konstantinos Tselios, Dafna D Gladman, Jiandong Su, Murray B Urowitz Tags: Original Article Source Type: research
More News: Angioplasty | Arthritis | Cardiology | Cardiovascular | Congestive Heart Failure | Coronary Angioplasty | Coronary Artery Bypass Graft | Diabetes | Endocrinology | Heart | Heart Attack | Heart Failure | Ischemic Stroke | Lupus | Nephritis | Proteinuria | Rheumatology | Stroke | Study